Amit Hazan
Stock Analyst at Goldman Sachs
(2.10)
# 2,792
Out of 5,182 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $55.07 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $10.01 | -75.02% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $0.88 | +2,056.89% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $15.81 | -49.40% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $63.41 | -0.65% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $150.22 | +81.07% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $15.88 | +7.05% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $4.40 | +9,797.61% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $24.09 | +82.65% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $83.46 | -12.53% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $18.49 | +186.64% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $24.54 | +132.27% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $10.36 | -8.30% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $92.80 | +12.07% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $22.28 | +169.30% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $82.92 | +38.69% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $329.01 | -54.41% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $59.95 | -23.27% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $470.99 | -48.69% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $92.59 | +91.17% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $225.34 | -34.77% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.44 | +777.19% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $55.07
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $10.01
Upside: -75.02%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $0.88
Upside: +2,056.89%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.81
Upside: -49.40%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $63.41
Upside: -0.65%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $150.22
Upside: +81.07%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $15.88
Upside: +7.05%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $4.40
Upside: +9,797.61%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $24.09
Upside: +82.65%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $83.46
Upside: -12.53%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $18.49
Upside: +186.64%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $24.54
Upside: +132.27%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $10.36
Upside: -8.30%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $92.80
Upside: +12.07%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $22.28
Upside: +169.30%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $82.92
Upside: +38.69%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $329.01
Upside: -54.41%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $59.95
Upside: -23.27%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $470.99
Upside: -48.69%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $92.59
Upside: +91.17%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $225.34
Upside: -34.77%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.44
Upside: +777.19%